Qdenga: Is it a Dengue Savior?

​Advancement has been made in healthcare, the discovery of Qdenga vaccine has become an important role in dengue fever prevention. Qdenga, which was just approved by Malaysia's Ministry of Health, promises to be efficient in treating dengue fever infections. 

What is Dengue?

Dengue fever, a mosquito viral disease, is a major health concern in many regions of the world. Symptoms include: 

• High temperature, up to 40C
• Severe headaches
• Joint and muscular pain

In severe cases can lead to dengue hemorrhagic fever or dengue shock syndrome.

Many efforts to prevent dengue fever have commonly been focused on the development of an effective vaccine. The ongoing search for such a vaccine has been prompted by the need to lessen the burden of dengue fever that can lead to death.

How was Qdenga developed?

What is Qdenga Vaccine?

The Qdenga vaccine is an important advancement in the global battle against dengue. Takeda Pharmaceuticals developed it to defend against all four serotypes of the dengue virus.

Qdenga vaccine should be given in two doses, with a three-month interval between each. Individuals who plan to take this vaccine must be at least 4 years old and above.

How does it differ from others?

Unlike some earlier dengue vaccine candidates, Qdenga has shown excellent performance in clinical testing, especially in reducing severe dengue cases. This defines it as a promising choice for dengue prevention.

Benefits of Qdenga Vaccine

• Protection from all four serotypes.

One of the most important benefits of the Qdenga vaccine is its capacity to produce immunity against all four dengue virus serotypes. This broad protection is critical in areas where numerous serotypes exist.

• Potential for Reducing Dengue Fever

By reducing severe dengue cases, the Qdenga vaccine has the potential to significantly decrease dengue fever impact on healthcare systems and society. 

Issues in Qdenga Vaccine

Safety and Side Effects

As with any vaccine, the safety of the Qdenga vaccine is important. Ongoing monitoring and research is needed to address any side effects. The side effects can be differ based on the individual:

• Discomfort and redness
• Swelling can occur at the injection site
• Fatigue or weakness
  

  

• Fever
• Headache
• Muscles ache

All of these side effects are considered usual and are not causing a risk to the individual, they are merely reactions to the vaccination entering the body. 

However, if these symptoms remain or get worse for more than 3-5 days following vaccinations, consult your doctor immediately.

What countries have approved Qdenga?

Takeda's Qdenga vaccine has been approved in several countries, including:

• Indonesia
• Malaysia
• Thailand 
• Argentina
• Brazil

Staged Introduction and Usage

The launch and use of the Qdenga vaccine are being carefully planned to assure widespread availability while overcoming technical challenges. 

These approvals may vary depending on the precise indications, age groups, and dose schedules permitted by each country's regulatory bodies.The availability and access to the vaccine may vary by country due to factors such as regulatory processes, healthcare facilities, and vaccination policy.

Future of the Qdenga Vaccine

The Qdenga vaccine is a promising technique for preventing dengue disease. Continued research and activation initiatives will be essential to maximizing the impact on public health.

Malaysia's Ministry of Health has approved the use of the Qdenga vaccine since early February. The Qdenga vaccine is safe to use in treating dengue fever cases in Malaysia, with an efficacy rate of up to 80%.

Individuals aged 4 years and above can receive the Qdenga vaccination, regardless of whether they have been infected with dengue fever.

To a better future!

The Qdenga vaccine is a source of hope in the fight against dengue disease. With its great efficacy and broad protection, it has the potential to make major contributions to lowering the global burden of this deadly disease. Ongoing support along with cooperation will be critical to achieving the full potential of this innovative vaccine. 

Click Here To Get The Qdenga Dengue Vaccine!

References

- “Dengue and severe dengue.” World Health Organization (WHO), 23 April 2024, https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue . Accessed 16 May 2024. 

- “Dengue Fever and the New Dengue Vaccine.” Samitivej Hospital in Bangkok, Thailand, https://www.samitivejhospitals.com/article/detail/dengue-fever-and-the-new-dengue-vaccine . Accessed 16 May 2024.

- “Dengue – Malaysian Society of Infectious Diseases & Chemotherapy.” Guidelines for Adult Immunisation, https://adultimmunisation.msidc.my/dengue/ . Accessed 17 May 2024.

- “QUEST 3+ Product Search.” QUEST 3+ Product Search, https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL24026010A. Accessed 20 June 2024.